Center for Epidemiology and Health Research, Germany
24
2
3
18
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
12.5%
3 terminated/withdrawn out of 24 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
56%
10 of 18 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
European Active Surveillance Study of LCS12
Role: lead
International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)
Role: lead
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
Role: lead
RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism
Role: lead
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
Role: lead
DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Role: lead
Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)
Role: lead
European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception
Role: lead
TRACY - Track My Cycle
Role: lead
Visanne Post-approval Observational Study (VIPOS)
Role: lead
INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)
Role: lead
Nexplanon Observational Risk Assessment Study (NORA)
Role: lead
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)
Role: lead
International Active Surveillance Study - Safety of Contraceptives: Role of Estrogens
Role: lead
Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs
Role: lead
European Active Surveillance Study for Intrauterine Devices
Role: lead
Surveillance Study of Women Taking Intrinsa®
Role: lead
European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)
Role: lead
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Role: lead
Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)
Role: lead